2-hydroxy-p-toluic acid

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

supporting study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

guideline study

Justification for type of information:

data is from experimental report

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2012

Report date:

2012

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Principles of method if other than guideline:

Acute Oral toxicity test was carried out to study the effects of Sodium salicylate (54-21-7) on rats.

GLP compliance:

yes

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

Sodium salicylate

EC Number:

200-198-0

EC Name:

Sodium salicylate

Cas Number:

54-21-7

Molecular formula:

C7H6O3Na

IUPAC Name:

sodium salicylate

Test material form:

solid: crystalline

Details on test material:

- Name of test material (IUPAC name): Sodium salicylate
- Common name: Monosodium salicylate
- Molecular formula: C7H6O3.Na
- Molecular weight: 160.1035 g/mol
- Smiles notation: c1(c(cccc1)O)C(=O)[O-].[Na+]
- InChl: 1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
- Substance type: Organic

Specific details on test material used for the study:

- Name of test material (as cited in study report): sodium salicylate
- Substance type: Organic
- Physical state: solid

Test animals

Species:

rat

Strain:

Wistar

Sex:

female

Details on test animals or test system and environmental conditions:

Age:7 to 9 weeks
Sex: Female, nulliparous and non pregnant. It has been observed that females are generally more sensitive than males to toxic effects
Body weight range:200±20g
Identification:By cage tag and corresponding colour body marking
Acclimation:One week in experimental room after veterinary examination.
Randomization:After acclimation and veterinary examination randomly selected in groups of three females.
Nutritional conditions:Fasted overnight prior to treatment. Food was offered three hours after dosing.

Husbandry
Environmental conditions:Air conditioned rooms with 10-15 air changes per hour, temperature between 22-25 0C, relative humidity 40-60% and illumination cycle set to 12 hours artificial fluorescent light and 12 hours dark.
Accommodation:Groups of three animals of similar sex in polypropylene cages with stainless steel grill top, facilities for food and water bottle, and bedding of clean paddy husk.
Diet:Pelleted feed
Water: Aqua Guard filter water was kept in PVC bottles, ad libitum

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

other: distilled water

Details on oral exposure:

24 hrs.

Doses:

No. of dose groups:Three + one vehicle control
Group I: Dist. water, 10ml/kg body wt.
Group II : 2000 mg/kg body wt.
Group III : 300 mg/kg body wt.
Group IV : 300 mg/kg body wt.

No. of animals per sex per dose:

No. of animals per dose group:Three (3 females)/step

Control animals:

not specified

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
BODY WEIGHT:
The body weight of all animals was observed weekly on day 0 (pre treatment),7th and 14th (post treatment).
CLINICAL SIGNS:
The treated animals were closely observed for clinical signs of intoxication ,first 4 hours and every 1 hours interval for 24 hrs after dosing and thereafter twice a day for 14 days.All rats were observed at least twice daily to observe any clinical signs or behavioral changes.
- Necropsy of survivors performed: yes,necropsy was carried out on all animals which died during the study or surviving animals were sacrified at the end of the study to observe any gross pathological changes.
- Other examinations performed: clinical signs, body weight,organ weights, histopathology study:The organ which showed gross pathological change during necropsy subjected for histopathological study.

Statistics:

no data available

Results and discussion

Preliminary study:

no data available

Effect levels

Sex:

female

Dose descriptor:

LD50 cut-off

Effect level:

500 mg/kg bw

Based on:

test mat.

Remarks on result:

other: 50% mortality was observed

Mortality:

Dose level 300 mg/kg b.wt
Step-I: The test compound did not produce any mortality throughout observation period.
Step-II: The test compound did not produce any mortality throughout the period of observation.
Dose level 2000 mg/kg b.wt.
All the Wistar albino rats died within the 4 hrs. of administration of test compound.

Clinical signs:

other: Dose level 300 mg/kg b.wt- Test compound did not produce any clinical signs of intoxication throughout the observation period of 14 days. Dose level 2000 mg/kg b.wt- Test compound produced high to sever signs of intoxication viz; abdominal respiration, c

Gross pathology:

Necropsy finding:

A.EXTRENAL:
i:skin: skin and hair coat was observed wet
ii:all external orifices: normal

B.INTERNAL:
i:subcutaneous: no change was observed
ii:superficial and deep lymph node: no change in mesenteric lymph node

ABDOMINAL CAVITY:
i. opening and general examination: in the abdominal cavity all the organs were present in normal position
ii. spleen: normal upto highest tested dose level 2000 mg/kg bw
iii. digestive sysytem: no gross changes were observed in stomach and intestine upto highest tested dose level 2000 mg/kg bw
iv. liver and biliary ducts: no gross pathological changes were observed
v. excretory sysytem: no gross pathological changes were observed upto highest tested dose level 2000 mg/kg bw
vi. adrenal: observed normal
vii. male/female genital organs: showed normal color,consistancy and no inflammartory changes upto highest tested dose level 2000 mg/kg bw

2. THORACIC CAVITY:
i. opening and general examination: thoracic cavity was found to be normal withut any fluid,mucous or blood etc.
ii. lungs: severe congestion was observed at the dose level of 2000 mg/kg bw
iii. heart: no changes were observed in color and consistancy. heart found normal upto highest tested dose level 2000 mg/kg bw
iv. thyroid: normal in shape,size and surface upto highest tested dose level 2000 mg/kg bw

3. CRANIAL CAVITY:
brain: normal in shape and size

Other findings:

no data available

Any other information on results incl. tables

SUMMARY OF BODY WEIGHT (GM)

Group	Day 0	Day 7	% Gain/loss	Day 14	% Gain/loss
Group-I distilled water 10ml/kg	211.10	215.91	3.76	219.5	6.28
Group-II 2000 mg/kg b. wt	205.11	-	-	-	-
Group-III 300 mg/kg b. wt	211.91	215.51	1.69	218.26	5.99
Group-IV 300 mg/kg b. wt	204.98	209.65	2.27	211.1	6.44

CLINICAL SIGNS AND MORTALITY

Group: I (Vehicle Control)                                                           Dose: 10 ml/kg b.wt

                                                                                                                                 

                                                           

FEMALE RATS

 

 

 

Parameters	Incidence of clinical signs observed after dosing																			Mortality
	Day 0					DAY
	Min	Hour
	30	1	2	4	6	1	2	3	4	5	6	7	8	9	10	11	12	13	14	Total^*
Mortality (total)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0/3
Clinical Signs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

 

0         =   No clinical sign (Normal)

+         =   Clinical Sign

CLINICAL SIGNS AND MORTALITY

Group: II                                                                                           Dose: 2000 mg/kg b. wt.

 

FEMALE RATS

 

Parameters	Incidence of clinical signs observed after dosing																			Mortality
	Day 0					DAY
	Min	Hour
	30	1	2	4	6	1	2	3	4	5	6	7	8	9	10	11	12	13	14	Total^*
Mortality (total)	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3/3
Clinical Signs	3	3	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Convulsion	++	+++	+++	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tremor	++	+++	++++	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Abdominal respiration	+++	+++	+++	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Paralysis	++	+++	+++	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

 

 0           =   Normal

+            =    Mild

++           =   Moderate

+++         =    High

++++      =   Severe

CLINICAL SIGNS AND MORTALITY

Group: III                                                                                          Dose: 300 mg/kg b.wt

                                            

 

FEMALE RATS

 

Parameters	Incidence of clinical signs observed after dosing																			Mortality
	Day 0					DAY
	Min	Hour
	30	1	2	4	6	1	2	3	4	5	6	7	8	9	10	11	12	13	14	Total
Mortality (total)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0/3
Clinical Signs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

 

0            =   Normal

+            =    Mild

++           =   Moderate

+++         =   High

 ++++=        Severe

CLINICAL SIGNS AND MORTALITY

Group: IV                                                                                         Dose: 300 mg/kg b.wt.

FEMALE RATS

 

Parameters	Incidence of clinical signs observed after dosing																			Mortality
	Day 0					DAY
	Min	Hour
	30	1	2	4	6	1	2	3	4	5	6	7	8	9	10	11	12	13	14	Total^*
Mortality (total)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0/3
Clinical Signs	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

 

0            =   Normal

+            =    Mild

++           =   Moderate

+++         =   High

++++      =   Severe

SUMMARY OF NECROPSY FINDINGS

 

S. No.	Fate	Wistar albino rats
		Dose (mg/kg b. wt)
		Distilled water (10 ml/kg)	2000	300	300
1	Terminal sacrifice	3/3	0/3	3/3	3/3
2	Found Dead	0/3	3/3	0/3	0/3
3	Abnormalities detected	NAD	Severe congestion In lung	NAD	NAD

 

 

NAD - No abnormality recorded

INDIVIDUAL ANIMAL FATE & NECROPSY FINDINGS

Group: I (Vehicle Control)                                                           Dose: 10ml/kg b.wt

                                                                                                                    

FEMALE RATS

 

Animal ID	Fate	Time	Gross Findings
20161-1	TS	Day 14	NAD
20161-2	TS	Day 14	NAD
20161-3	TS	Day 14	NAD

 

Day 0 is the day of dose administration.

TS- Terminal Sacrifice

NAD- No abnormality Detected

INDIVIDUAL ANIMAL FATE & NECROPSY FINDINGS

Group: II                                                                                            Dose: 2000 mg/kg b.wt.                  

FEMALE RATS

 

Animal ID	Fate	Time	Gross Findings
20161-4	FD	4 hrs.	Severe congestion in lungs
20161-5	FD	4 hrs.
20161-6	FD	4 hrs.

 

Day 0 is the day of dose administration.

TS- Terminal Sacrifice

NAD- No abnormality Detected

FD- Found Dead

Applicant's summary and conclusion

Interpretation of results:

Toxicity Category IV

Conclusions:

The lethal concentration (LD50) cut-off value for acute oral toxicity test was considered to be 500 mg/kg bw,when female wistar albino rats were treated with sodium salicylate (CAS No. 54-21-7) orally via gavage according to OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method).

Executive summary:

The acute oral toxicity profile of sodium salicylate (CAS No. 54-21-7) in female wistar albino rats according to OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method).The test substance was dissolved in Distilled water to obtain final concentration of 30 and 200 mg/ml which was administered by oral route by using oral cannula.Body weight,mortality and clinical signs were observed in treated animals.at dose level 300 mg/kg bw,Test compound did not produce any clinical signs of intoxication throughout the observation period of 14 days.atdose level 2000 mg/kg bw,Test compound produced high to sever signs of intoxication viz; abdominal respiration, convulsion, tremor and hind leg paralysis and finally death after 4 hrs.All the animals treated with CAS No. 54-21-7 at the dose level of 300 mg/kg bw showed decrease in normal gain in body weight on day 7th as compared to control group. Whereas, on day 14th all the rats showed normal gain weight as compared to control group.Hence,The lethal concentration (LD50) cut-off value for acute oral toxicity test was considered to be 500 mg/kg bw,when female wistar albino rats were treated with sodium salicylate (CAS No. 54-21-7) orally via gavage according to OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method).